跳至主要内容
临床试验/JPRN-jRCTs032210224
JPRN-jRCTs032210224已完成未知

Verification study of the new peripheral intravenous catheter for reducing catheter failure incidence: A randomized controlled trial

Mineo Kurokawa0 个研究点目标入组 50 人开始时间: 2021年8月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

This study confirmed the effectiveness of CF reduction by using a new catheter placed on the upper arm vein compared to a short catheter placed on the forearm vein for patients administered irritant drugs. New catheters did not increase the incidence of adverse events and lead to treatment interruption due to device malfunction.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients must satisfy the followings; .
  • 1) Patients are scheduled to administrate stimulant drugs using peripheral intravenous catheter.
  • 2) Over 19 years, regardless of gender
  • 3) Patients are scheduled to continuous infusion therapy over 24 hours
  • 4) Patients give us their written consent for the study
  • 5) The first catheterization at this hospitalization

排除标准

  • The following patients must be excluded.
  • 1) Patients are unable to maintain the position to fully rotate the shoulder joint and rotate the elbow joint
  • 2) Having skin disorders at the puncture site
  • 3) Having peripheral neuropathy
  • 4) Having a history of vasovagal reflex due to puncture
  • 5) Having a history of thrombosis
  • 6) With end-stage renal disease (stage 2 or higher)
  • 7) Having abnormal blood coagulation or bleeding tendency (PT-INR 1.5 or more, APTT 36.1 seconds or more, while taking any anticoagulant or antiplatelet drugs)
  • 8) Patient is planned of highly invasive tests (endoscopy, bronchoscopy)
  • 9) Participation of this study is judged inappropriate for patient by physician

研究者

发起方
Mineo Kurokawa

相似试验